(Infocast News) Audited results of China Regenerative Medicine International Limited (08158) for the fiscal year ended 31 December 2019:
Net loss: HK$395.006M (HK$1.1935B net loss for the same period last year)
Basic LPS: HK$0.449
Dividend per share proposed: (Nil)
(WL)